132 related articles for article (PubMed ID: 34247488)
1. Initial Stages of Spontaneous Binding of Folate-Based Vectors to Folate Receptor-α Observed by Unbiased Molecular Dynamics.
Schaber EN; Ivanova N; Iliev S; Petrova J; Gocheva G; Madjarova G; Ivanova A
J Phys Chem B; 2021 Jul; 125(28):7598-7612. PubMed ID: 34247488
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional insights on folate receptor α (FRα) by homology modeling, ligand docking and molecular dynamics.
Della-Longa S; Arcovito A
J Mol Graph Model; 2013 Jul; 44():197-207. PubMed ID: 23880302
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight.
Al-Thiabat MG; Saqallah FG; Gazzali AM; Mohtar N; Yap BK; Choong YS; Wahab HA
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670773
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of a Folate Receptor-α Anchored into a Multilipid Bilayer Obtained from Atomistic Molecular Dynamics Simulations.
Gocheva G; Ivanova N; Iliev S; Petrova J; Madjarova G; Ivanova A
J Chem Theory Comput; 2020 Jan; 16(1):749-764. PubMed ID: 31639310
[TBL] [Abstract][Full Text] [Related]
5. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for molecular recognition of folic acid by folate receptors.
Chen C; Ke J; Zhou XE; Yi W; Brunzelle JS; Li J; Yong EL; Xu HE; Melcher K
Nature; 2013 Aug; 500(7463):486-9. PubMed ID: 23851396
[TBL] [Abstract][Full Text] [Related]
8. Molecular simulation of the structure of folate and antifolates at physiological conditions.
Petrova J; Gocheva G; Ivanova N; Iliev S; Atanasova B; Madjarova G; Ivanova A
J Mol Graph Model; 2019 Mar; 87():172-184. PubMed ID: 30553157
[TBL] [Abstract][Full Text] [Related]
9. Intermediate states in the binding process of folic acid to folate receptor α: insights by molecular dynamics and metadynamics.
Della-Longa S; Arcovito A
J Comput Aided Mol Des; 2015 Jan; 29(1):23-35. PubMed ID: 25323390
[TBL] [Abstract][Full Text] [Related]
10. Study of folate-based carbon nanotube drug delivery systems targeted to folate receptor α by molecular dynamic simulations.
Jiang Y; Wang C; Zhang M; Liu L; Gao X; Zhang S; Ye D
Int J Biol Macromol; 2023 Jul; 244():125386. PubMed ID: 37327924
[TBL] [Abstract][Full Text] [Related]
11. Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
Kamen BA; Smith AK
Cancer Chemother Pharmacol; 2012 Jul; 70(1):113-20. PubMed ID: 22644798
[TBL] [Abstract][Full Text] [Related]
12. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
13. Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Chu H; Shillingford JM; Reddy JA; Westrick E; Nelson M; Wang EZ; Parker N; Felten AE; Vaughn JF; Xu LC; Lu YJ; Vlahov IR; Leamon CP
Mol Pharm; 2019 Sep; 16(9):3985-3995. PubMed ID: 31356752
[TBL] [Abstract][Full Text] [Related]
14. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
15. Interaction mechanism of novel fluorescent antifolates targeted with folate receptors α and β via molecular docking and molecular dynamic simulations.
Wang C; Zhang M; Shi S; Jiang Y; Fei X; Liu L; Ye D; Zhang S
J Mol Model; 2022 Jul; 28(8):205. PubMed ID: 35780236
[TBL] [Abstract][Full Text] [Related]
16. Type and size effect of functional groups on the novel antifolate target recognition folate receptors α and β: Docking, molecular dynamics and MM/PBSA study.
Jiang Y; Wang C; Zhang M; Fei X; Gu Y
J Mol Graph Model; 2020 Nov; 100():107663. PubMed ID: 32659629
[TBL] [Abstract][Full Text] [Related]
17. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
Kuplennik N; Lang K; Steinfeld R; Sosnik A
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
[TBL] [Abstract][Full Text] [Related]
18. Novel fluorescent antifolates that target folate receptors α and β: Molecular dynamics and density functional theory study.
Wang C; Jiang Y; Zhang M; Fei X; Gu Y
J Mol Graph Model; 2018 Oct; 85():40-47. PubMed ID: 30055477
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier.
Golani LK; Islam F; O'Connor C; Dekhne AS; Hou Z; Matherly LH; Gangjee A
Bioorg Med Chem; 2020 Jun; 28(12):115544. PubMed ID: 32503687
[TBL] [Abstract][Full Text] [Related]
20. Binding and Release between Polymeric Carrier and Protein Drug: pH-Mediated Interplay of Coulomb Forces, Hydrogen Bonding, van der Waals Interactions, and Entropy.
De Luca S; Chen F; Seal P; Stenzel MH; Smith SC
Biomacromolecules; 2017 Nov; 18(11):3665-3677. PubMed ID: 28880549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
